Medtronic's 2019 acquisition of Titan Spine continues to make the company's spine portfolio shine. This week during the virtual North American Spine Society (NASS) meeting, Medtronic launched the Adaptix Interbody System, which features Titan nanoLOCK surface technology.
Interbody implants are spacers that can be inserted between the vertebrae during spinal fusion surgery to help relieve pressure on nerves and hold the vertebrae in place while fusion occurs. Implant material and shape is thought to play a role in the bone growth process during fusions, and today there is a growing demand from surgeons for titanium interbody devices. Titan Spine pioneered the spine implant surface technology category. Titan nanoLOCK is a blend of surface textures on the macro, micro, and nano levels.
FDA approved the Adaptix system in August, but Medtronic chose to launch the product in conjunction with the NASS meeting. The device is mirrored after the veteran Capstone spinal system, and Medtronic touts that Adaptix offers increased strength, subsidence resistance, easy insertion, and data-backed bone growth.
Medtronic said the Adaptix system is compatible with its StealthStation Navigation and O-arm imaging platform as well as the newly released Grafton DBF Inject, a unique graft delivery syringe that delivers an osteoinductive DBM into the surgical site.
"Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK surface technology," said Sharrolyn Josse, vice president and general manager of Medtronic core spine and biologics division, which is part of the company's restorative therapies group. "It is a fully navigated procedure, leveraging our leadership in navigation."
Other Spine News from NASS 2020
Stryker has expanded its lateral spine portfolio with the full launch of its Niagra Lateral Access System following the completion of 600 surgeries. Niagara is designed to allow surgeons control through precision, visibility, and flexibility. The broad array of instruments is designed for all types of lateral lumbar fusion surgery. From straightforward to complex procedures, total blade precision allows for direct device deployment and thorough disc preparation to streamline workflow and potentially help reduce operative time with lumbar fusion procedures, anterior to psoas approaches, corpectomies and complex cases, including multi-level and deformity correction.
Stryker said the new system's PEEK-infused carbon fiber features integrated illumination to further enhance visibility intraoperatively, which said can reduce the need for intraoperative, image-driven adjustments. The company said this material formulation was specifically engineered to give surgeons the visibility of carbon fiber with the strength and firmness of steel, and even demonstrated equivalence to metal-based retractors in a benchtop test.
Stryker noted that the Niagara system complements its existing lateral portfolio, including the Cascadia Lateral 3D Interbody System featuring Lamellar 3D titanium technology, the Aleutian Lateral Interbody System, the Cayman United Plate System and the Ravine Lateral Access System.
“Niagara reiterates our mission – together with our customers, we are driven to make healthcare better – which has held strong throughout the COVID-19 pandemic,” said Eric Major, president of Stryker’s spine division. “Designed in collaboration with leading surgeons specializing in lateral lumbar interbody fusion, Niagara represents a key addition to our minimally invasive lateral portfolio to help ensure that surgeons have the most advanced tools they need to meet a wide variety of operative needs.”
Also at NASS, Orthofix Medical launched its new O-Genesis graft delivery system (pictured below), designed to deliver allograft, autograft, or synthetic bone graft to orthopedic surgical sites. The company also introduced the AlloQuent Structural Allograft Q-Pack, a hydrated, ready-to-use form of cervical and lumbar spacers for allograft procedures.
"The unique design of the O-Genesis graft delivery system enables one-handed delivery of bone graft material in a precise and controlled manner to aid surgeons with the targeted placement of biologics during orthopedic surgeries," said Kevin Kenny, global president of Orthofix Medical's spine business. "Additionally, we are pleased to offer the new AlloQuent Structural Allograft in Q-Pack that allows for immediate use with no downtime for rehydrating. Both of these demonstrate our commitment to providing surgeons with easy-to-use solutions to meet the needs of their patients.”